GlassScriptPhysician profile
Ursula V Roeder
NPI 1588667232
$511.76
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $113 · 2020: $9.79 · 2021: $14.80 · 2022: $135 · 2023: $42.83 · 2024: $196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $239.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $135.14 | 2022 | |
| Pfizer INC. | $101.93 | 2024 | |
| Amgen INC. | $93.58 | 2019 | |
| Dilon Technologies, INC. | $51.63 | 2023-2024 | Hemoblast Bellows |
| Merck Sharp & Dohme LLC | $28.43 | 2024 | Lynparza, Keytruda |
| Progenics Pharmaceuticals, INC. | $21.77 | 2023 | Pylarify |
| Daiichi Sankyo INC. | $21.26 | 2024 | Enhertu |
| Genentech USA, INC. | $19.20 | 2019 | |
| Myovant Sciences INC. | $14.80 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $14.23 | 2024 | Imfinzi |
| Merit Medical Systems INC | $9.79 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ursula Roeder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.